Figure 2.
Figure 2. Outcome analyses for PAX5P80R patients. (A) EFS and (B) OS, after censoring patients at the time of allogeneic stem cell transplantation, according to the presence of PAX5P80R. (C) EFS and (D) OS of PAX5P80R cases as compared with defined cytogenetic subtypes, without censoring patients who received allogeneic stem cell transplantation.

Outcome analyses for PAX5P80Rpatients. (A) EFS and (B) OS, after censoring patients at the time of allogeneic stem cell transplantation, according to the presence of PAX5P80R. (C) EFS and (D) OS of PAX5P80R cases as compared with defined cytogenetic subtypes, without censoring patients who received allogeneic stem cell transplantation.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal